Late-breaking study results reinforce positive real-world outcomes with the watchman flx™ laac device

Marlborough, mass., feb. 28, 2022 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced positive results from a new analysis assessing real-world outcomes with the watchman flx™ left atrial appendage closure (laac) device.
BSX Ratings Summary
BSX Quant Ranking